Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Given Consensus Recommendation of “Hold” by Brokerages

Shares of Carl Zeiss Meditec AG (OTCMKTS:CZMWY) have received an average rating of “Hold” from the six brokerages that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and one has given a buy recommendation to the company.

A number of brokerages have recently commented on CZMWY. UBS Group cut Carl Zeiss Meditec from a “neutral” rating to a “sell” rating in a research note on Tuesday. Zacks Research upgraded Carl Zeiss Meditec from a “strong sell” rating to a “hold” rating in a research report on Monday, July 13th.

Carl Zeiss Meditec Stock Performance

Shares of Carl Zeiss Meditec stock opened at $34.63 on Tuesday. The company’s 50 day moving average price is $31.96 and its two-hundred day moving average price is $31.12. Carl Zeiss Meditec has a fifty-two week low of $26.65 and a fifty-two week high of $55.94.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.